85 related articles for article (PubMed ID: 21144845)
1. Serial serum free light chain measurements do not detect changes in disease status earlier than electrophoretic M-spike measurements in patients with intact immunoglobulin myeloma.
Uljon SN; Richardson PG; Schur PH; Anderson KC; Tanasijevic MJ; Lindeman NI
Clin Chim Acta; 2011 Mar; 412(7-8):562-8. PubMed ID: 21144845
[TBL] [Abstract][Full Text] [Related]
2. Correlations among different markers determined by immunochemical methods used for the diagnosis and monitoring of intact immunoglobulin multiple myeloma cases.
Dogaru M; Lazăr V; Coriu D
Roum Arch Microbiol Immunol; 2012; 71(4):183-200. PubMed ID: 23755700
[TBL] [Abstract][Full Text] [Related]
3. [Detection of serum free light chain and its clinical significance in nonsecretory multiple myeloma].
Chen HF; Hou J; Yuan ZG; Wang DX; Fu WJ; Chen YB
Zhonghua Xue Ye Xue Za Zhi; 2008 Feb; 29(2):113-6. PubMed ID: 18681313
[TBL] [Abstract][Full Text] [Related]
4. Serum free light chains for monitoring multiple myeloma.
Mead GP; Carr-Smith HD; Drayson MT; Morgan GJ; Child JA; Bradwell AR
Br J Haematol; 2004 Aug; 126(3):348-54. PubMed ID: 15257706
[TBL] [Abstract][Full Text] [Related]
5. Prediction of response and progression in multiple myeloma with serum free light chains assay: corroboration of the serum free light chain response definitions.
Khoriaty R; Hussein MA; Faiman B; Kelly M; Kalaycio M; Baz R
Clin Lymphoma Myeloma Leuk; 2010 Feb; 10(1):E10-3. PubMed ID: 20223721
[TBL] [Abstract][Full Text] [Related]
6. Assessing the efficiency of free light chain assay in monitoring patients with multiple myeloma before and after autologous stem cell transplantation along with serum protein electrophoresis and serum protein immunofixation.
Dogaru M; Lazăr V; Coriu D
Roum Arch Microbiol Immunol; 2011; 70(1):15-22. PubMed ID: 21717807
[TBL] [Abstract][Full Text] [Related]
7. [Assessment of serum free light chain of patients with multiple myeloma and clinical significance thereof].
Sui WW; Yao HJ; Wang YF; Wang L; Zhang K; Xu Y; Qiu LG
Zhonghua Yi Xue Za Zhi; 2007 Nov; 87(44):3158-60. PubMed ID: 18269880
[TBL] [Abstract][Full Text] [Related]
8. Normalization of free light chain kappa/lambda ratio is a robust prognostic indicator of favorable outcome in patients with multiple myeloma.
Iwama K; Chihara D; Tsuda K; Ugai T; Sugihara H; Nishida Y; Yamakura M; Takeuchi M; Matsue K
Eur J Haematol; 2013 Feb; 90(2):134-41. PubMed ID: 23210517
[TBL] [Abstract][Full Text] [Related]
9. Renal monoclonal immunoglobulin deposition disease: a report of 64 patients from a single institution.
Nasr SH; Valeri AM; Cornell LD; Fidler ME; Sethi S; D'Agati VD; Leung N
Clin J Am Soc Nephrol; 2012 Feb; 7(2):231-9. PubMed ID: 22156754
[TBL] [Abstract][Full Text] [Related]
10. Light-chain removal by plasmapheresis in myeloma-associated renal failure.
Cserti C; Haspel R; Stowell C; Dzik W
Transfusion; 2007 Mar; 47(3):511-4. PubMed ID: 17319833
[TBL] [Abstract][Full Text] [Related]
11. [Evaluation of the clinical relevance of serum measurements of free-light chains in patients with multiple myeloma].
Shimizu K; Itoh J; Sugiura I; Tsushita K; Kosugi H; Nagura E
Rinsho Ketsueki; 2006 Apr; 47(4):303-9. PubMed ID: 16715965
[TBL] [Abstract][Full Text] [Related]
12. Immunological classification of 31 multiple myeloma patients.
Qiu WX; Huang NH; Wu GH
Proc Chin Acad Med Sci Peking Union Med Coll; 1990; 5(2):79-83. PubMed ID: 2123037
[TBL] [Abstract][Full Text] [Related]
13. Diagnosis and monitoring for light chain only and oligosecretory myeloma using serum free light chain tests.
Heaney JLJ; Campbell JP; Griffin AE; Birtwistle J; Shemar M; Child JA; Gregory WM; Cairns DA; Morgan G; Jackson G; Drayson MT
Br J Haematol; 2017 Jul; 178(2):220-230. PubMed ID: 28573706
[TBL] [Abstract][Full Text] [Related]
14. Serum free light chain measurements to reduce 24-h urine monitoring in patients with multiple myeloma with measurable urine monoclonal protein.
Tschautscher M; Rajkumar V; Dispenzieri A; Lacy M; Gertz M; Buadi F; Dingli D; Hwa L; Fonder A; Hobbs M; Hayman S; Zeldenrust S; Lust J; Russell S; Leung N; Kapoor P; Go R; Lin Y; Gonsalves W; Kourelis T; Warsame R; Kyle R; Kumar S
Am J Hematol; 2018 Oct; 93(10):1207-1210. PubMed ID: 30016549
[TBL] [Abstract][Full Text] [Related]
15. [Clinical significance of serum free light chain in patients with multiple myeloma].
Zhang SS; Wu S; Qu XY; Xu J; Liu P; Lu H; Wu HX; Xu JR; Li JY; Chen LJ
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2013 Aug; 21(4):930-5. PubMed ID: 23998588
[TBL] [Abstract][Full Text] [Related]
16. Antibodies contained in "M" component of some patients with multiple myeloma are directed to food antigens?
Juranić Z; Radic J; Konic-Ristic A; Jelic S; Besu I; Mihaljevic B
Leuk Res; 2006 Dec; 30(12):1585-6. PubMed ID: 16516966
[TBL] [Abstract][Full Text] [Related]
17. 'Light-chain escape-multiple myeloma'-an escape phenomenon from plateau phase: report of the largest patient series using LC-monitoring.
Kühnemund A; Liebisch P; Bauchmüller K; zur Hausen A; Veelken H; Wäsch R; Engelhardt M
J Cancer Res Clin Oncol; 2009 Mar; 135(3):477-84. PubMed ID: 18802723
[TBL] [Abstract][Full Text] [Related]
18. [Non-secretory myeloma of heavy mu-chain type].
Leglise MC; Briere J; Abgrall JF; Hurez D
Nouv Rev Fr Hematol (1978); 1983; 25(2):103-6. PubMed ID: 6408608
[TBL] [Abstract][Full Text] [Related]
19. Serum free light chain response after 2 courses of induction chemotherapy predicts prognosis in myeloma patients.
Yağcı M; Karakaya F; Suyanı E; Haznedar R
Clin Lymphoma Myeloma Leuk; 2015 Feb; 15(2):98-102. PubMed ID: 25441109
[TBL] [Abstract][Full Text] [Related]
20. Biclonal gammopathy in multiple myeloma: a case report.
Bakta IM; Sutarka IN
Gan To Kagaku Ryoho; 2000 May; 27 Suppl 2():544-8. PubMed ID: 10895208
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
